Samil Pharmaceutical Co.,Ltd (KRX:000520)

KRX:000520 Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 19, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	239,683	279,170	96,901	108,894	106,418	128,907
Market Cap Growth	-16.68%	188.10%	-11.01%	2.33%	-17.45%	0.33%
Enterprise Value	397,635	420,498	272,367	265,842	202,048	200,995
Last Close Price	11290.00	13150.00	6700.00	7800.00	7509.09	9184.43
PE Ratio	-	-	58.25	-	-	96.16
PS Ratio	1.11	1.27	0.49	0.61	0.79	1.05
PB Ratio	1.68	1.59	0.76	0.87	1.62	2.03
P/TBV Ratio	1.72	1.63	0.77	0.89	1.65	2.09
P/OCF Ratio	-	107.79	8.25	26.22	75.11	16.58
EV/Sales Ratio	1.85	1.91	1.39	1.48	1.51	1.63
EV/EBITDA Ratio	-	57.52	23.03	29.52	39.53	18.72
EV/EBIT Ratio	-	8739.66	42.16	66.19	505.45	30.74
EV/FCF Ratio	-43.30	-	-	-	-	-
Debt / Equity Ratio	1.15	0.85	1.38	1.27	1.91	1.49
Debt / EBITDA Ratio	-	20.53	14.87	17.68	24.55	8.79
Net Debt / Equity Ratio	1.10	0.82	1.37	1.25	1.68	1.22
Net Debt / EBITDA Ratio	-44.97	19.83	14.79	17.47	21.57	7.19
Net Debt / FCF Ratio	-17.20	-52.11	-14.00	-3.55	-3.51	-8.35
Asset Turnover	0.56	0.57	0.54	0.62	0.64	0.66
Inventory Turnover	4.02	4.13	4.27	4.59	3.53	3.18
Quick Ratio	0.28	0.38	0.22	0.27	0.38	0.48
Current Ratio	0.61	0.86	0.48	0.56	0.63	0.74
Return on Equity (ROE)	-17.04%	-3.70%	1.31%	-0.03%	-8.27%	2.13%
Return on Assets (ROA)	-2.71%	0.01%	1.11%	0.86%	0.12%	2.18%
Return on Invested Capital (ROIC)	-5.45%	0.01%	2.21%	-0.05%	0.25%	4.90%
Return on Capital Employed (ROCE)	-7.20%	0.00%	3.20%	1.80%	0.40%	7.00%
Earnings Yield	-11.29%	-2.02%	1.72%	-0.03%	-5.02%	1.04%
FCF Yield	-3.83%	-1.00%	-12.90%	-40.71%	-29.52%	-7.17%
Dividend Yield	-	-	-	-	-	0.74%
Payout Ratio	-	-	-	-	-	68.55%
Buyback Yield / Dilution	-24.53%	-24.32%	-3.75%	-0.82%	-2.85%	-0.13%
Total Shareholder Return	-24.53%	-24.32%	-3.75%	-0.82%	-2.85%	0.62%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.